Avalo Therapeutics, Inc. · NASDAQ:AVTX

Point72 Asset Management, L.P.'s stake in Avalo Therapeutics, Inc. fell to 3.50% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Point72 Asset Management, L.P.'s stake in Avalo Therapeutics, Inc. fell to 3.50%, 627,502 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
3.50%
Shares
627,502
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.3.50%627,502
Point72 Capital Advisors, Inc.3.50%627,502
Steven A. Cohen3.50%627,502

Source

View original at SEC

Related